慢性阻塞性肺疾病患者在全肩关节置换术后发生肺炎、感染性休克和输血的风险更高
基于美国外科医师学会国家手术质量改进计划数据库2005至2016年间14,494例全肩关节置换术患者,其中931例(6%)有慢性阻塞性肺疾病(COPD)病史。多变量回归分析显示,COPD是全肩关节置换术后肺炎(OR 2.793)、导致输血的出血(OR 1.577)和感染性休克(OR 9.259)的独立危险因素。作者建议对COPD患者术后降低感染怀疑阈值,并可考虑使用氨甲环酸以减少输血需求。
要点
- COPD是全肩关节置换术后肺炎的独立危险因素(OR 2.793,95%CI 1.426-5.471,p=0.003)。
- COPD是全肩关节置换术后感染性休克的独立危险因素(OR 9.259,95%CI 2.140-40.057,p=0.003)。
- COPD是全肩关节置换术后导致输血的出血的独立危险因素(OR 1.577,95%CI 1.155-2.154,p=0.004)。
核心结论
- COPD是全肩关节置换术后30天内肺炎、导致输血的出血和感染性休克的独立危险因素。
- 鉴于这些严重并发症风险增加,作者认为外科医生应对全肩关节置换术后COPD患者的感染保持较低的怀疑阈值,以便在发展为肺炎和感染性休克等严重感染并发症前采取充分措施。
- 作者建议可考虑对接受全肩关节置换术的COPD患者使用氨甲环酸以减少输血需求。
- 作者认为有必要通过随机对照试验分析更积极的感染预防措施降低肺炎/感染性休克风险的有效性,以及氨甲环酸降低COPD患者全肩关节置换术后输血需求的作用。
研究设计与样本
- 回顾性数据库研究,查询美国外科医师学会国家手术质量改进计划(ACS-NSQIP)数据库,纳入2005年至2016年间接受全肩关节置换术的14,494例患者。
- 排除接受肩关节半肩置换术和翻修肩关节置换术的患者。
- 14,494例患者中931例(6%)有COPD病史,比较COPD组与非COPD组的人口学因素、合并症和术后30天内急性并发症差异。
- 采用单变量分析评估人口学特征、合并症和围手术期/术后结局的患病率差异,采用多变量回归分析评估COPD作为并发症独立危险因素。
- 证据等级为III级,治疗性研究。
主要发现
- COPD组931例(6%)与非COPD组在人口学因素、合并症和术后30天内急性并发症方面进行分析。
- 多变量回归显示COPD是全肩关节置换术后肺炎的独立危险因素(OR 2.793,95%CI 1.426-5.471,p=0.003)。
- COPD是导致输血的出血的独立危险因素(OR 1.577,95%CI 1.155-2.154,p=0.004)。
- COPD是感染性休克的独立危险因素(OR 9.259,95%CI 2.140-40.057,p=0.003)。
关键数值与推荐
- 肺炎:OR 2.793(95%CI 1.426-5.471,p=0.003),COPD组相对于非COPD组。
- 导致输血的出血:OR 1.577(95%CI 1.155-2.154,p=0.004),COPD组相对于非COPD组。
- 感染性休克:OR 9.259(95%CI 2.140-40.057,p=0.003),COPD组相对于非COPD组。
临床怎么用
- 作者认为外科医生应对全肩关节置换术后COPD患者的感染保持较低的怀疑阈值,以便在发展为肺炎和感染性休克等严重感染并发症前采取充分措施。
- 作者建议可考虑对接受全肩关节置换术的COPD患者使用氨甲环酸以减少输血需求。
局限性
- 作者认为有必要通过随机对照试验分析更积极的感染预防措施降低肺炎/感染性休克风险的有效性,以及氨甲环酸降低COPD患者全肩关节置换术后输血需求的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic obstructive pulmonary disease (COPD) has been associated with several complications after surgery, including pneumonia, myocardial infarction, septic shock, and mortality. To the authors' knowledge, there has been no work analyzing the impact of COPD on complications after total shoulder arthroplasty (TSA). Although previous work has elucidated the complications COPD has on TKA and THA, extrapolating the results of lower extremity arthroplasty to TSA may prove to be inaccurate. Compared with lower extremity arthroplasty, TSA is a relatively new procedure that has only recently gained popularity. Therefore, this study seeks to elucidate COPD's effects on complications in TSA specifically so that postoperative care can be tailored for these patient populations. Assessing these patients may enable surgeons to implement preoperative precautionary measures to prevent serious adverse events in these patients. QUESTIONS/PURPOSES: What serious postoperative complications are patients with COPD at risk for within the 30-day postoperative period after TSA? METHODS: The American College of Surgeons National Surgical Quality Improvement Program® (ACS-NSQIP) database was queried to identify 14,494 patients who had undergone TSA between 2005 and 2016, excluding patients who had undergone hemiarthroplasties of the shoulder and revision shoulder arthroplasties. The ACS-NSQIP database was utilized in this study for the comprehensive preoperative and postoperative medical histories it provides for each patient for 274 characteristics. Among the 14,494 patients undergoing TSA, 931 (6%) patients who had a history of COPD were identified, and the two cohorts-COPD and non-COPD-were analyzed for differences in their demographic factors, comorbidities, and acute complications occurring within 30 days of their procedure. Univariate analyses were utilized to assess differences in the prevalence of demographic features, comorbidities, and perioperative/postoperative outcomes after surgery. Multivariate regression analyses were used to assess COPD as an independent risk factor associated with complications. RESULTS: COPD is an independent risk factor for three complications after TSA: pneumonia (odds ratio [OR], 2.793; 95% confidence interval [CI], 1.426-5.471; p = 0.003), bleeding resulting in transfusion (OR, 1.577; 95% CI, 1.155-2.154; p = 0.004), and septic shock (OR, 9.259; 95% CI, 2.140-40.057; p = 0.003). CONCLUSIONS: In light of the increased risk of these serious complications, surgeons should have a lower threshold of suspicion for infection in patients with COPD after TSA so that adequate measures can be taken before developing severe infectious complications including pneumonia and septic shock. Surgeons may also consider administering tranexamic acid in patients with COPD undergoing TSA to reduce the amount of blood transfusions necessary. Future work through randomized control trials analyzing (1) the effectiveness of more aggressive infection prophylaxis in decreasing the risk of pneumonia/septic shock; and (2) the use of tranexamic acid in decreasing blood transfusion requirements in patients with COPD undergoing TSA is warranted. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Lee R, Lee D, Mamidi IS, et al. Patients With Chronic Obstructive Pulmonary Disease Are at Higher Risk for Pneumonia, Septic Shock, and Blood Transfusions After Total Shoulder Arthroplasty. Clin Orthop Relat Res. 2019. PMID: 30664604. doi:10.1097/CORR.0000000000000531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。